SCHEMBL30890495

SCHEMBL30890495

CCCCOC(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 2/20 0.36
PLA2G5 P39877 2/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
MCL1 Q07820 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
EPHX1 P07099 1/20 0.35
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
KMT2A Q03164 1/20 0.34
ACHE P22303 6/20 0.34
CTSL P07711 2/20 0.33
CTSB P07858 2/20 0.33
CTSS P25774 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890737 0.82 PSEN1 (0.41) PLA2G2APLA2G5CTSLCTSBCTSS
SCHEMBL7375873 0.79 ALDH1A1 (0.39) PLA2G2APLA2G5NPC1RAB9ASMN1; SMN2
SCHEMBL27244933 0.77 CTSK (0.45) L3MBTL1MEN1KMT2ACTSLCTSB
SCHEMBL27244791 0.77 CTSK (0.45) L3MBTL1MEN1KMT2ACTSLCTSB
SCHEMBL459573 0.77 EPHX1 (0.47) NPC1RAB9ASMN1; SMN2HPGDALDH1A1
SCHEMBL459574 0.77 EPHX1 (0.47) NPC1RAB9ASMN1; SMN2HPGDALDH1A1
SCHEMBL476725 0.77 EPHX1 (0.47) NPC1RAB9ASMN1; SMN2HPGDALDH1A1
SCHEMBL6824840 0.76 PLA2G2A (0.55) PLA2G2APLA2G5ALDH1A1MAPTMEN1
SCHEMBL1068731 0.76 PLA2G2A (0.55) PLA2G2APLA2G5ALDH1A1MAPTMEN1
SCHEMBL2455888 0.76 PLA2G2A (0.55) PLA2G2APLA2G5ALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 WO disclosed